| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |